Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Gains from Investment Securities (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Gains from Investment Securities for 3 consecutive years, with -$172541.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities fell 101.14% year-over-year to -$172541.0, compared with a TTM value of -$987565.0 through Sep 2025, down 102.05%, and an annual FY2024 reading of $30.2 million, up 69.48% over the prior year.
  • Gains from Investment Securities was -$172541.0 for Q3 2025 at SBC Medical Group Holdings, up from -$20.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $20.6 million in Q1 2025 and bottomed at -$20.3 million in Q2 2025.
  • Average Gains from Investment Securities over 3 years is $5.9 million, with a median of $7.6 million recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 27.24% in 2025, while the deepest fall reached 108931.19% in 2025.
  • Year by year, Gains from Investment Securities stood at $16.8 million in 2023, then plummeted by 106.5% to -$1.1 million in 2024, then skyrocketed by 84.22% to -$172541.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SBC at -$172541.0 in Q3 2025, -$20.3 million in Q2 2025, and $20.6 million in Q1 2025.